Correlation between hyperglycemia and glycated albumin with retinopathy of prematurity

Ana C Almeida1,2,3,4,5, Gabriela A Silva6, Gabriele Santini7

  • 1Department of Ophthalmology, Hospital Beatriz Angelo, Loures, Av. Carlos Teixeira 3, 2674-514, Loures, Portugal. acralmeida@yahoo.com.

Scientific Reports
|November 17, 2021
PubMed

Insights

Hyperglycemia, or high blood sugar, is a significant risk factor for retinopathy of prematurity (ROP). Glycated albumin (GlyA) levels were not found to be a significant predictor of ROP in premature infants.

Area of Science:

  • Neonatal Medicine
  • Ophthalmology
  • Endocrinology

Background:

  • Retinopathy of prematurity (ROP) is a leading cause of visual impairment in premature infants.
  • Hyperglycemia and glycated albumin (GlyA) are potential risk factors for ROP, but their association requires further investigation.

Purpose of the Study:

  • To determine the association between hyperglycemia, glycated albumin (GlyA), and retinopathy of prematurity (ROP) in a cohort of premature infants.
  • To identify significant risk factors for ROP development.

Main Methods:

  • Prospective study of 152 infants requiring ROP screening between March 2017 and July 2019.
  • Collected demographic, clinical, and laboratory data, including glucose measurements and serum GlyA levels at multiple time points.
  • Employed univariate and multivariate logistic regression analyses to assess risk factors for ROP.

Main Results:

  • Thirty-three infants (21.7%) developed ROP.
  • Hyperglycemia was present in 72.7% of infants with ROP compared to 0.05% without ROP.
  • Multivariate analysis identified hyperglycemia as a significant independent risk factor for ROP (Exp(B) 28.062, p < 0.001), while GlyA was not significant.

Conclusions:

  • Hyperglycemia is a critical and independent risk factor for retinopathy of prematurity in premature infants.
  • Glycated albumin (GlyA) levels do not appear to be a significant predictor of ROP in this cohort.
  • Findings emphasize the importance of glycemic control in preventing ROP.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.2K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.0K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.3K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
443
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
25.9K